Yu‐Ning Hu
Papers
1
Total Citations
4
H-Index
1
About
Dr. Yu‐Ning Hu is a distinguished urologic surgeon and researcher whose work centers on advancing minimally invasive surgical techniques for renal cancer treatment. His primary research focuses on nephron-sparing surgery, particularly the refinement of robotic-assisted laparoscopic partial nephrectomy (RALPN) to achieve "zero ischaemia"—a critical goal that preserves kidney function during tumor removal. Dr. Hu’s most notable contribution is the clinical application of preoperative superselective transarterial embolization (STE) to enable bloodless, ischemia-free tumor resection. In a landmark 2023 study, he demonstrated the feasibility and safety of this combined approach in 32 patients with T1 renal cancer, showing that STE effectively devascularizes tumors while maintaining renal perfusion. This work has garnered significant attention, with 4 citations already, and represents a paradigm shift in organ-sparing oncology. Dr. Hu’s innovative integration of interventional radiology and robotic surgery has positioned him as a pioneer in reducing surgical morbidity, offering patients a safer alternative to traditional clamping techniques. His ongoing research continues to push the boundaries of precision oncology, making him a leading voice in the evolution of kidney cancer surgery.
Research Focus
Key Achievements
Top Papers
- 1